Literature DB >> 9681995

Activation of Glut1 glucose transporter in human erythrocytes.

J Z Zhang1, F Ismail-Beigi.   

Abstract

Glut1, the only glucose transporter isoform expressed in the human red blood cell (RBC), binds to and is inhibited by cytochalasin B (CB). In the present study we show that incubation of RBC ghost membranes with 10 microM cytochalasin E (CE) results in a 1.8-fold increase in the number of glucose-sensitive cytochalasin B binding sites. Moreover, treatment with CE was associated with no observable change in the protein composition of RBC ghosts determined by SDS-PAGE. Removal of surface ("extrinsic") proteins from RBC ghosts by treatment with 0.2 mM EDTA (pH 12) for 30 min resulted in a similar 1.8-fold increase in the number of glucose-sensitive CB binding sites. Western blot analysis showed that treatment with CE or EDTA resulted in no change in the amount or mobility of Glut1 present in ghost membranes. Glucose transport, measured as CB-inhibitable 3-O-[3H]methylglucose uptake by resealed ghosts, was stimulated in CE-treated resealed ghosts, with the t1/2 to equilibrium decreasing from 6.8 +/- 0.5 to 3.9 +/- 0.3 s (P < 0.05). Treatment of ghosts with CE or EDTA followed by Western blotting of samples in the presence or absence of beta-mercaptoethanol resulted in no change in immunoreactivity or mobility of the major Glut1 band. The above results suggest that a significant fraction of Glut1 transporters exists in an inactive form ("masked") in RBC plasma membranes and that treatment of ghosts with CE or EDTA leads to an apparent activation of Glut1. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681995     DOI: 10.1006/abbi.1998.0760

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  Protein interactions with the glucose transporter binding protein GLUT1CBP that provide a link between GLUT1 and the cytoskeleton.

Authors:  R C Bunn; M A Jensen; B C Reed
Journal:  Mol Biol Cell       Date:  1999-04       Impact factor: 4.138

2.  Activation of the extraneuronal monoamine transporter (EMT) from rat expressed in 293 cells.

Authors:  Dirk Gründemann; Ann-Cathrin Koschker; Christine Haag; Cornelius Honold; Tim Zimmermann; Edgar Schömig
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

3.  Hypoxia Signaling Cascade for Erythropoietin Production in Hepatocytes.

Authors:  Yutaka Tojo; Hiroki Sekine; Ikuo Hirano; Xiaoqing Pan; Tomokazu Souma; Tadayuki Tsujita; Shin-ichi Kawaguchi; Norihiko Takeda; Kotaro Takeda; Guo-Hua Fong; Takashi Dan; Masakazu Ichinose; Toshio Miyata; Masayuki Yamamoto; Norio Suzuki
Journal:  Mol Cell Biol       Date:  2015-05-26       Impact factor: 4.272

4.  Immunometabolic adaptation and immune plasticity in pregnancy and the bi-directional effects of obesity.

Authors:  April Rees; Oliver Richards; Megan Chambers; Benjamin J Jenkins; James G Cronin; Catherine A Thornton
Journal:  Clin Exp Immunol       Date:  2022-06-11       Impact factor: 5.732

5.  Adolescents with clinical type 1 diabetes display reduced red blood cell glucose transporter isoform 1 (GLUT1).

Authors:  Meena Garg; Manikkavasagar Thamotharan; Dorothy J Becker; Sherin U Devaskar
Journal:  Pediatr Diabetes       Date:  2014-02-19       Impact factor: 4.866

6.  Glucose transporter-1 distribution in fibrotic lung disease: association with [¹⁸F]-2-fluoro-2-deoxyglucose-PET scan uptake, inflammation, and neovascularization.

Authors:  Souheil El-Chemaly; Daniela Malide; Jianhua Yao; Steven D Nathan; Ivan O Rosas; William A Gahl; Joel Moss; Bernadette R Gochuico
Journal:  Chest       Date:  2013-06       Impact factor: 9.410

7.  Protein disulfide isomerase may facilitate the efflux of nitrite derived S-nitrosothiols from red blood cells.

Authors:  Vasantha Madhuri Kallakunta; Anny Slama-Schwok; Bulent Mutus
Journal:  Redox Biol       Date:  2013-07-16       Impact factor: 11.799

8.  Poly((D,L)lactic-glycolic)acid-star glucose nanoparticles for glucose transporter and hypoglycemia-mediated tumor targeting.

Authors:  Ju-Hwan Park; Hyun-Jong Cho; Dae-Duk Kim
Journal:  Int J Nanomedicine       Date:  2017-10-11

9.  Angiotensin II Modulates Podocyte Glucose Transport.

Authors:  Barbara Lewko; Anna Maryn; Elzbieta Latawiec; Agnieszka Daca; Apolonia Rybczynska
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-24       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.